Bupropion in dermatology: A brief update.
anti-inflammatory effects
antidepressants
bupropion
cutaneous disorders
Journal
Dermatologic therapy
ISSN: 1529-8019
Titre abrégé: Dermatol Ther
Pays: United States
ID NLM: 9700070
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
25
08
2020
revised:
05
09
2020
accepted:
09
09
2020
pubmed:
15
9
2020
medline:
25
5
2021
entrez:
14
9
2020
Statut:
ppublish
Résumé
There is currently an interest in evaluating the role that antidepressants may play in the treatment of primary cutaneous disorders. It has been proposed that antidepressants could have anti-inflammatory effects, but the clinical relevance of this effect has not been adequately established. In the case of bupropion, evidence for its specific use in dermatologic conditions currently come only from a pilot study and a case report. While this level of evidence is unlikely to be sufficient to guide clinical practice, the authors of this brief update hope to sort the available information to serve as a guide and provide a structure for future research.
Substances chimiques
Antidepressive Agents
0
Bupropion
01ZG3TPX31
Types de publication
Journal Article
Review
Langues
eng
Sous-ensembles de citation
IM
Pagination
e14303Informations de copyright
© 2020 Wiley Periodicals LLC.
Références
Ferris RM, Maxwell RA, Cooper BR, Soroko FE. Neurochemical and neuropharmacological investigations into the mechanisms of action of bupropion. HCl: a new atypical antidepressant agent. Adv Biochem Psychopharmacol. 1982;31:277-286.
Schatzberg AF, Nemeroff CB, American Psychiatric Association Publishing, eds. The American Psychiatric Association Publishing Textbook of Psychopharmacology. 5th ed. Arlington, VA: American Psychiatric Association Publishing; 2017:1791.
de Battista C, Schatzberg AF. Bupropion. Kaplan & Sadock's Comprehensive Textbook of Psychiatry. 10th ed. Philadelphia: Lippincott Williams & Wilkins; 2017.
Bupropion. In: Lexi-drugs online [database on the Internet]. Hudson (OH): Lexicomp, Inc.; 2016 [updated 5 Sep 2020; cited 17 Sep 2020]. Available from: http://online.lexi.com. Subscription required to view.
Stahl SM. Stahl's Essential Psychopharmacology: Neuroscientific Basis and Practical Application. 4th ed. Cambridge, New York: Cambridge University Press; 2013:608.
Roddy E. Bupropion and other non-nicotine pharmacotherapies. BMJ. 2004;328(7438):509-511.
Stahl SM, Grady MM. Stahl's Essential Psychopharmacology: Prescriber's Guide. 6th ed. Cambridge, UK; New York, NY: Cambridge University Press; 2017:868.
Eskeland S, Halvorsen JA, Tanum L. Antidepressants have anti-inflammatory effects that may be relevant to dermatology: a systematic review. Acta Derm Venereol. 2017;97(8):897-905.
Altschuler EL, Kast RE. Bupropion in psoriasis and atopic dermatitis: decreased tumor necrosis factor-alpha? Psychosom Med. 2003;65(4):719.
Modell JG. Treatment of atopic dermatitis and psoriasis vulgaris with bupropion-SR: a pilot study. Psychosom Med. 2002;64(5):835-840.
González E, Sanguino R, Franco M. Bupropion in atopic dermatitis. Pharmacopsychiatry. 2006;39(6):229-229.
Beyens M-N, Guy C, Mounier G, Laporte S, Ollagnier M. Serious adverse reactions of bupropion for smoking cessation: analysis of the French pharmacovigilance database from 2001 to 2004. Drug Saf. 2008;31(11):1017-1026.
Tak H, Koçak C, Sarıcı G, Dizen Namdar N, Kıdır M. An uncommon side effect of bupropion: a case of acute generalized exanthematous pustulosis. Case Rep Dermatol Med. 2015;2015:421765.
Ray AK, Wall GC. Bupropion-induced acute generalized exanthematous pustulosis. Pharmacotherapy. 2011;31(6):621-621.
Tackett AE, Smith KM. Bupropion-induced angioedema. Am J Health Syst Pharm. 2008;65(17):1627-1630.
Bhella R, Southgate J. Angioedema caused by bupropion treatment. Acute Med. 2010;9(2):70-72.
Chiang C-K, Chou Y-H, Chen Y-H, Sha C-B, Liang C-S. Aphthous ulcers associated with bupropion in a female adolescent: a case verified by rechallenge. Gen Hosp Psychiatry. 2011;33(4):411.e1-411.e2.
Salgado N, Benavente S, Coll JM, Vives A. Drug eruption due to bupropion, a case report. Eur Psychiatry. 2016;33(S1):S619-S620.
Hannah CE, Little AJ, Wanat KA, Fairley JA. Drug-induced cutaneous lupus erythematosus: a case series of five patients with bupropion-associated disease. J Clin Rheumatol Pract Rep Rheum Musculoskelet Dis. 2018. https://doi.org/10.1097/RHU.0000000000000882.
Akgür S, Güllülü S, Dilek K, et al. A case report of cutaneous and systemic lupus erythematosus after bupropion usage. Turk J Intern Med. 2020;2(3):91-94.
Lineberry TW, Peters GE, Bostwick JM. Bupropion-induced erythema multiforme. Mayo Clin Proc 2001;76(6):664-666.
Matos-Pires E, Campos S, Mendes-Bastos P, João A, Fernandes C. Erythrodermic psoriasis induced by bupropion. J Eur Acad Dermatol Venereol. 2017;31(2):e129-e130.
Jumez N, Dereure O, Bessis D, Guillot B. Flare of cutaneous lupus erythematosus induced by bupropion (Zyban). Dermatology. 2004;208(4):362-362.
Polat M, Uzun Ö, Örs İ, Boran Ç. Pityriasis rosea-like drug eruption due to bupropion: a case report. Hum Exp Toxicol. 2014;33(12):1294-1296.
Cox NH, Gordon PM, Dodd H. Generalized pustular and erythrodermic psoriasis associated with bupropion treatment. Br J Dermatol. 2002;146(6):1061-1063.
Nguyen CV, Miller DD. Serum sickness-like drug reaction: two cases with a neutrophilic urticarial pattern: serum sickness-like drug reaction: two cases with a neutrophilic urticarial pattern. J Cutan Pathol. 2017;44(2):177-182.
McCollom RA, Elbe DH, Ritchie AH. Bupropion-induced serum sickness-like reaction. Ann Pharmacother. 2000;34(4):471-473.
Waibel KH, Katial RK. Serum sickness-like reaction and bupropion. J Am Acad Child Adolesc Psychiatry. 2004;43(5):509-509.
de Santiago Hernando ML, Gutiérrez Agramunt A, Muñoz Gómez B, de Santiago Hernando ML. Enfermedad del suero-like asociada a bupropión [Bupropion-associated serum-like disease]. Med Clín. 2002;119(2):76.
Yolles JC, Armenta WA, Alao AO. Serum sickness induced by bupropion. Ann Pharmacother. 1999;33(9):931-933.
Surovik J, Riddel C, Chon SY. A case of bupropion-induced Stevens-Johnson syndrome with acute psoriatic exacerbation. J Drugs Dermatol JDD. 2010;9(8):1010-1012.
Cassis TB, Callen JP. Bupropion-induced subacute cutaneous lupus erythematosus. Australas J Dermatol. 2005;46(4):266-269.
Aykut T, Recep D, Munise D, Arzu A, İlkay Ö. A case of bupropion-induced toxic epidermal necrolysis (TEN). Ann Clin Case Rep. 2017;2:1396.
Tuman TC, Tuman BA, Göksügür N, Kayka N, Yıldırım O. Urticaria and angioedema associated with bupropion: three cases. Prim Care Companion CNS Disord. 2016;18(4).